▩ ID9606/2a-c: Dispositive eines Virus
◈ Treatment of hepatitis C

Type: Journal Article

Identifier:
4Y9NU73P
| issn:
1352-0504, Search publication in worldcat.org , 1365-2893 Search publication in worldcat.org
| doi:
10.1111/j.1365-2893.2005.00600.x Search article via doi.org
Description

SUMMARY. The combination of pegylated interferon alpha and ribavirin has improved treatment success rates in patients with hepatitis C with sustained response rates of just over 50% overall and more than 70% for those with genotypes 2 and 3. This article reviews the use of combination therapy, contraindications, factors influencing response and describes approaches to specific patient groups.
Related people

Heathcote, J. (creator)
Main, J. (creator)